An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function
FAST-CMR
Assessment and Validation of the Established Free-Running Framework for Cardiac Function by Magnetic Resonance Imaging (FAST-CMR): An International Multi-Center, Multi-Vendor Study at 1.5T
1 other identifier
observational
300
10 countries
20
Brief Summary
This project aims to evaluate a new cardiac MRI technique called the Free-Running Framework (FRF), which could simplify and accelerate the process of acquiring cardiac images. The investigators want to verify whether this method can provide functional heart measurements comparable to those obtained with traditional methods. More specifically, the goal of the study is to compare the measurements obtained with FRF to those obtained with standard sequences, to ensure they match and that this new approach can be reliably used in clinical practice. The FRF technique works differently from standard cardiac MRI. In standard exams, patients are asked to hold their breath several times and small electrodes (ECG) are used to monitor the heartbeat during the scan. These steps are needed to get clearer images of the heart as it moves. With FRF, these steps are no longer necessary: the scan is performed while patients' breath normally and without ECG monitoring. In addition, standard MRI takes multiple 2D slices of the heart, one after another. The FRF method instead captures a 3D image of the entire heart in one go, which can improve the consistency of the exam and reduce errors when doctors analyze the images later. This is all possible because the FRF method records data continuously and then organizes the images afterward based on how participants heart and breathing were moving during the exam. This helps the imager to get clear images of the heart, even without breath-holding or ECG monitoring. This project is aimed at individuals with heart disease who require cardiac MRI exams to monitor their health status (age ≥ 18 years) and are able to clearly understand the instructions provided by the research team. The investigators have already conducted small-scale technical and feasibility studies using FRF. These studies have shown that FRF is easy to use, faster than traditional methods, and provides image quality comparable to standard imaging techniques. The investigators now wish to evaluate its use in a clinical setting. More specifically, the investigators need to verify that FRF provides the same essential diagnostic information as standard techniques, so that it can be reliably used in future patient care. A maximum of 300 participants will be included in the investigation of this MRI technique between 2026 and 2031. This is a multi-center study, conducted internationally across 18 centers. This project is being carried out in compliance with Swiss legislation. The investigators follow all internationally recognized guidelines. The competent ethics committee has reviewed and approved this project.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2026
Longer than P75 for all trials
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2026
CompletedFirst Posted
Study publicly available on registry
May 29, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2030
May 29, 2026
April 1, 2026
1.6 years
February 27, 2026
May 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mean paired difference (bias) in left ventricular ejection fraction (LVEF) between 5D FISS-FRF and conventional 2D cine CMR
estimated with a two-sided 95% confidence interval within each pre-defined patient cohort. The study is designed to ensure that the half-width of this confidence interval does not exceed 1.25% LVEF per cohort.
Baseline (during study MRI acquisition)
Secondary Outcomes (20)
Scan Efficiency
Baseline (during study MRI acquisition)
Quantitative Image Quality
Baseline (during study MRI acquisition)
Qualitative Image Quality
Baseline (during study MRI acquisition)
Failure Rate
Baseline (during study MRI acquisition)
Anatomical Coverage
Baseline (during study MRI acquisition)
- +15 more secondary outcomes
Study Arms (3)
Patients with congenital heart disease
FAST-CMR will evaluate the technique's performance in complex, heterogeneous anatomy.
Patients unable to perform breath-holding
including those with advanced heart failure, pulmonary hypertension, or chronic obstructive pulmonary disease (COPD), representing a subgroup where conventional breath-held CMR techniques are often suboptimal or not feasible.
Other cardiovascular disease patients who are able to perform breath-holding
This group represents the standard patient population for whom conventional CMR is currently optimized.
Eligibility Criteria
This study will prospectively include 300 patients (\~15-20 per site) with known or suspected cardiac disease who are referred for a clinically indicated CMR scan as part of their routine clinical work-up.
You may qualify if:
- Diagnosed with cardiac disease of any complexity and scheduled for a clinical cardiac MRI on a clinical 1.5T MRI scanner
- Able to understand and provide written informed consent or, for minors, ability to provide assent with written consent from a parent/legal representative, per local law and site policy prior to the study
- Ability to undergo MRI without contraindications
- Agrees to be informed in the event of incidental findings
You may not qualify if:
- Severe claustrophobia preventing MRI completion
- Presence of non-MRI compatible implants (e.g., pacemakers, certain metallic implants)
- Contraindications to the intravenous contrast agent
- Movement disorders or inability to remain still during the scan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Matthias Stuberlead
- Mayo Cliniccollaborator
- University of California, Los Angelescollaborator
Study Sites (20)
University of California, Los Angeles
Los Angeles, California, 90095, United States
Emory University
Atlanta, Georgia, 30322, United States
Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
Boston's Children Hospital
Boston, Massachusetts, 02115, United States
Mayo Clinic
Rochester, Minnesota, 55902, United States
Washington University in St. Louis
St Louis, Missouri, 63130, United States
Ohio State University
Columbus, Ohio, 43210, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
University of Melbourne
Melbourne, Victoria, 3010, Australia
Fundacion Cardioinfantil-LaCardio
Bogotá, Capital District, 111156, Colombia
University of Bonn
Bonn, North Rhine-Westphalia, 53113, Germany
Cologne University Medical Center
Cologne, North Rhine-Westphalia, 50931, Germany
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany
Università Cattolica - Fondazione Policlinico Gemelli IRCCS
Rome, Lazio, 00168, Italy
Mie University
Tsu, Mie-ken, 514-8507, Japan
Maastricht University Medical Center
Maastricht, Limburg, 6229 HX, Netherlands
National University of Singapore
Singapore, Singapore, 119275, Singapore
University of Cape Town
Cape Town, Western Cape, 7700, South Africa
King's College London
London, London, WC2R2LS, United Kingdom
Related Publications (5)
Ogier AC, Baup S, Ilanjian G, Touray A, Rocca A, Banus J, Monton Quesada I, Nicoletti M, Ledoux JB, Richiardi J, Holtackers RJ, Yerly J, Stuber M, Hullin R, Rotzinger D, van Heeswijk RB. Cardiac function assessment with deep-learning-based automatic segmentation of free-running four-dimensional whole-heart cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2025 Dec 24;28(1):102677. doi: 10.1016/j.jocmr.2025.102677. Online ahead of print.
PMID: 41453741BACKGROUNDKoktzoglou I, Edelman RR. Radial fast interrupted steady-state (FISS) magnetic resonance imaging. Magn Reson Med. 2018 Apr;79(4):2077-2086. doi: 10.1002/mrm.26881. Epub 2017 Aug 30.
PMID: 28856788BACKGROUNDYerly J, Roy CW, Milani B, Eyre K, Raifee MJ, Stuber M. High on sparsity: Interbin compensation of cardiac motion for improved assessment of left-ventricular function using 5D whole-heart MRI. Magn Reson Med. 2025 Mar;93(3):975-992. doi: 10.1002/mrm.30323. Epub 2024 Oct 9.
PMID: 39385350BACKGROUNDBastiaansen JAM, Piccini D, Di Sopra L, Roy CW, Heerfordt J, Edelman RR, Koktzoglou I, Yerly J, Stuber M. Natively fat-suppressed 5D whole-heart MRI with a radial free-running fast-interrupted steady-state (FISS) sequence at 1.5T and 3T. Magn Reson Med. 2020 Jan;83(1):45-55. doi: 10.1002/mrm.27942. Epub 2019 Aug 27.
PMID: 31452244BACKGROUNDDi Sopra L, Piccini D, Coppo S, Stuber M, Yerly J. An automated approach to fully self-gated free-running cardiac and respiratory motion-resolved 5D whole-heart MRI. Magn Reson Med. 2019 Dec;82(6):2118-2132. doi: 10.1002/mrm.27898. Epub 2019 Jul 18.
PMID: 31321816BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Stuber, PhD
CHUV
- PRINCIPAL INVESTIGATOR
Tim Leiner, MD, PhD
Mayo Clinic
- PRINCIPAL INVESTIGATOR
Kim-Lien Nguyen, MD
University of California, Los Angeles
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor and Section Head CIBM MRI CHUV-UNIL
Study Record Dates
First Submitted
February 27, 2026
First Posted
May 29, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
September 1, 2030
Last Updated
May 29, 2026
Record last verified: 2026-04